57 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
6 Mar 24
Adaptimmune Reports Q4 /Full Year 2023 Financial Results and Business Updates
7:05am
approval with commercial, manufacturing, and supply chain teams preparing for product delivery
Lete-cel program transitioned back to Adaptimmune … afami-cel’s commercial supply from the Company’s Navy Yard cell therapy manufacturing facility in Philadelphia. Adaptimmune’s manufacturing and supply
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Adaptimmune or TCR2’s product … and their impact on Adaptimmune’s and TCR2’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials
425
gwv98i7r
30 May 23
Business combination disclosure
4:21pm
8-K
674pb0trzacrfq4o3
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
m87v23iq6ul
22 May 23
Business combination disclosure
7:01am
8-K
cuq 83q8ouy7tdzon6z
22 May 23
Other Events
6:59am
8-K
EX-99.1
gvg4lcx4ngfxtih2bg
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
6f3wr6 15dv
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
gg143
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
8gcfco5e9e0
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm